Skip to content

Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy

Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy: a Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06189859
Enrollment
52
Registered
2024-01-05
Start date
2024-03-16
Completion date
2025-08-31
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia, Achalasia Cardia

Keywords

achalasia, POEM, ELECTROSURGERY, SPRAY COAGULATION, PERORALENDOSCOPIC ESOPHAGEAL MYOTOMY

Brief summary

Peroral endoscopic esophagel myotomy (POEM) is a third space endoscopy technique that depends on creating a submucosal tunnel to expose the esophageal muscle and eventually perform an esophageal myotomy. Submucosal dissection can be performed using numerous electrosurgical modes. Spray coagulation has been anecdotally favored by many endoscopists due to its high coagulation power and assumed safety. Recently, Precisect mode has been developed, it has theoretical advantages of very minimal tissue penetration and minimal to no charring effect. In this trial, the investigators compare the efficacy and safety of both electrosurgical modes in POEM procedures.

Interventions

PROCEDUREendoscopic submucosal dissection using Precisect mode

After initial mucosal incision, submucosal dissection will be performed down to 2cm below the cardia using Precisect mode using ERBE VIO3 generator and a Hybrid knife (T-type) aided by ERBEJET for submucosal injection

PROCEDUREendoscopic submucosal dissection using SPRAY COAG mode

After initial mucosal incision, submucosal dissection will be performed down to 2cm below the cardia using Spray coag mode using ERBE VIO3 generator and a Hybrid knife (T-type) aided by ERBEJET for submucosal injection

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Allocation of patients will be in sealed envelopes to be opened on day of the procedure. The investigator and care provider (same) will thus be unmasked. Participant and outcomes assessor will remain masked until the end of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing POEM procedure for any esophageal motility disorder * Esophageal motility disorder confirmed by high-resolution manometry and gastroscopy

Exclusion criteria

* Esophageal varices * Esophageal neoplasms * Non-correctable coagulopathy * Failure to provide an informed consent

Design outcomes

Primary

MeasureTime frameDescription
Speed of endoscopic submucosal dissectionduring the procedureSpeed of dissection (cm/minute)

Secondary

MeasureTime frameDescription
Intraprocedural Bleedingduring the procedureBleeding necessitating change in electrosurgical mode
Significant Intraprocedural bleedingduring the procedureBleeding necessitating change of instrument to coagulating forceps
Other Adverse eventsduring the procedureIncluding mucosal injury, postoperative pain, postoperative bleeding and other complications
Total procedure durationduring the procedureTotal procedure duration
Endoscopic submucosal tunneling durationduring the procedureEndoscopic submucosal tunneling duration

Countries

Egypt

Contacts

Primary Contacthany Shehab, MD, FRCP
h.shehab@kasralainy.edu.eg+201111111071

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026